Justin – Financial24

THCA Flower in 2026: What to Look for Before You Buy

March 17, 2026 by Justin

Close-up of premium THCA hemp flower buds with frosty trichomes and vibrant colors in 2026

In 2026, THCA flower remains a popular hemp-derived alternative offering high potency and familiar cannabis-like experiences through decarboxylation, but evolving federal and state regulations, including shifts toward total THC calculations, create uncertainty. Key factors for buyers include verifying third-party lab tests for potency and purity, assessing cultivation methods, examining terpene profiles for flavor and effects, … Read more

Nvidia Pushes Further Into Real World AI

March 17, 2026 by Justin

**” Nvidia is accelerating its dominance in physical AI, unveiling advanced open models like Cosmos 3 and Isaac GR00T N1.7 at GTC 2026, enabling robots and autonomous systems to reason, act, and deploy in complex real-world environments. Partnerships with global robotics leaders are scaling production across industries, while new platforms like Vera Rubin power agentic … Read more

The Best Warren Buffett Stocks to Buy With $1,000 Right Now

March 15, 2026 by Justin

Warren Buffett stocks portfolio chart featuring top holdings like Apple, American Express, Coca-Cola for investing with $1000

“With $1,000, investors can gain exposure to timeless businesses that embody Warren Buffett’s principles of strong moats, consistent earnings, and shareholder-friendly management. Berkshire Hathaway’s top holdings like Apple, American Express, Coca-Cola, Bank of America, and Chevron offer a mix of technology innovation, financial stability, consumer staples reliability, and energy resilience—ideal for long-term compounding in the … Read more

VR Adviser Boosts Stake in Savara Inc. with Addition of Over 1 Million Shares

March 15, 2026 by Justin

VR Adviser hedge fund increasing investment position in Savara Inc. biotechnology stock chart with SVRA ticker

“Institutional investor VR Adviser significantly increased its position in Savara Inc. (NASDAQ: SVRA) by acquiring more than 1 million additional shares in the most recent quarter. This move elevates VR Adviser’s holdings to over 13.7 million shares, representing a substantial portion of the biotech’s outstanding shares and underscoring continued confidence in the company’s rare disease … Read more

PPL Corporation’s Investment Narrative Evolves with Ambitious Capital Plan and Extended Growth Targets

March 14, 2026 by Justin

PPL Corporation headquarters building with utility power lines and grid infrastructure in the background, representing energy sector growth.

PPL Corporation has significantly enhanced its long-term growth profile following its latest update, announcing a boosted $23 billion capital expenditure plan for 2026-2029, new 2026 EPS guidance of $1.90-$1.98, and an extension of its 6%-8% annual EPS growth target through at least 2029. The company anticipates achieving a compound annual growth rate near the top … Read more

Earendil Labs and WuXi Biologics Forge Strategic Alliance to Fast-Track Bispecific, Multispecific Antibodies, and ADCs

March 13, 2026 by Justin

Microscopic view of bispecific antibodies and ADCs targeting cancer cells in a laboratory setting

“Earendil Labs, an AI-powered innovator in next-generation biologics, has partnered with WuXi Biologics, a leading global CRDMO, to advance multiple pipeline candidates including bispecific and multispecific antibodies as well as antibody-drug conjugates (ADCs) targeting cancer, autoimmune diseases, and other serious conditions. The deal leverages WuXi’s comprehensive development and GMP manufacturing expertise to speed up timelines, … Read more

MariMed Inc (MRMD) Q4 2025 Earnings: What Investors Should Anticipate

March 11, 2026 by Justin

Stock chart and financial data overlay for MariMed Inc (MRMD) Q4 2025 earnings expectations

“MariMed Inc. (MRMD), a multi-state cannabis operator focused on branded consumer packaged goods and retail, is scheduled to report its fourth quarter and full-year 2025 results imminently. Wall Street consensus points to revenue around $40.6 million to $40.8 million for the quarter, with a per-share loss of $0.01. Full-year figures are projected at approximately $161 … Read more

Ascend Wellness Holdings Inc (AAWH) Q4 2025 Earnings Report Preview: What To Expect

March 11, 2026 by Justin

“Ascend Wellness Holdings is poised to report its Q4 2025 results on March 12, 2026, with preliminary guidance pointing to approximately $120 million in net revenue and $30 million in Adjusted EBITDA, reflecting a 25% margin amid ongoing industry pressures. Despite a sequential revenue dip from Q3’s $124.7 million and a year-over-year decline, the company … Read more

Becton Dickinson Product Launches Aim To Deepen Recurring Hospital Revenue

March 8, 2026 by Justin

Becton Dickinson medical devices including syringes, infusion systems, and wound irrigation solutions in a hospital setting

Becton Dickinson (BD) is strategically rolling out innovative products in medication management, surgical safety, vascular access, and connected care solutions, reinforcing its position as a pure-play MedTech leader with over 90% recurring revenue. Recent launches like the Surgiphor™ 1000mL wound irrigation system, next-generation BD Pyxis™ Pro dispensing solution with AI-enabled BD Incada™ platform, and expansions … Read more

C.H. Robinson’s AI Supply Chain Push Meets Supreme Court Risk Question

March 8, 2026 by Justin

C.H. Robinson headquarters building with digital AI network overlay representing supply chain innovation and a subtle Supreme Court gavel in the background

C.H. Robinson is aggressively advancing its Lean AI and Agentic Supply Chain platform, deploying over 30 AI agents to automate millions of logistics tasks, optimize operations, and deliver real-time decision-making for shippers and carriers. This innovation positions the company as a leader in transforming global supply chains through intelligent, adaptive technology. However, a major U.S. … Read more